Researchers have discovered a single protein that can control both the sense of touch and the experience of chronic pain. This protein, a potassium channel called TWIK-1, acts like a molecular switch in the spinal cord and peripheral nerves. The finding, published in the journal Signal Transduction and Targeted Therapy, points to a new way to treat persistent pain that does not respond to current medications.

Key takeaways

  • TWIK-1 is a potassium channel found in the spinal cord and sensory neurons that regulates touch and pain signals.
  • When researchers removed TWIK-1 in mice, the animals became more sensitive to light touch and developed chronic pain.
  • The study suggests that TWIK-1 normally keeps touch and pain signals in check, and its failure may cause neuropathic pain.
  • This protein could be a new target for drugs that treat chronic pain without affecting normal touch sensation.

What is TWIK-1 and where is it found?

TWIK-1 is a type of potassium channel, a protein that allows potassium ions to flow through cell membranes. These channels are essential for controlling the electrical activity of nerve cells. The research team, led by Prof. Hyosang Lee from the Department of Brain Sciences at DGIST in South Korea, found that TWIK-1 is expressed in the spinal cord and in peripheral sensory neurons. These are the nerve cells that carry information about touch, pressure, and pain from the skin to the brain.

Potassium channels like TWIK-1 help set the resting state of a nerve cell. When they are working properly, they make it harder for the cell to fire off a signal. This means they act as natural brakes on nerve activity. The DGIST team wanted to know if TWIK-1 specifically controls how the nervous system processes touch and pain.

How the switch was discovered

The researchers used mice that were genetically modified to lack the TWIK-1 channel. They then tested how these mice responded to different types of touch and pain. The results were striking. Mice without TWIK-1 were much more sensitive to light touch. A gentle brush of their fur, which normal mice barely notice, caused them to react strongly. This condition is called allodynia, where a normally harmless stimulus becomes painful.

Furthermore, the mice developed signs of chronic neuropathic pain. Neuropathic pain is a type of persistent pain that often follows nerve injury. It is notoriously difficult to treat with standard painkillers. The study suggests that when TWIK-1 is missing or not working, the spinal cord loses its ability to filter out normal touch signals. These signals then get amplified and interpreted as pain.

A new target for chronic pain treatment

Current treatments for chronic pain often have limited effectiveness or serious side effects. Many drugs work by blocking pain signals broadly, which can also affect normal sensation and lead to drowsiness or addiction. The discovery of TWIK-1 offers a more precise target.

According to the original report from Medical Xpress, the study presents a new molecular mechanism in the spinal cord that regulates touch responses. It also reveals a potential cause of persistent neuropathic pain. By understanding how TWIK-1 works, researchers may be able to develop drugs that restore its function or mimic its effects. This could reduce pain without interfering with other sensations.

What this means for patients

For people living with chronic pain, this research offers hope for a new class of treatments. Neuropathic pain affects millions of people worldwide and is a common complication of conditions like diabetes, shingles, and spinal cord injuries. Current options often provide only partial relief.

The discovery of TWIK-1 as a molecular switch does not mean a new drug is available tomorrow. The research is still at an early stage, conducted in mice. However, it identifies a specific protein that could be targeted by future medications. The next steps would involve confirming the role of TWIK-1 in human pain pathways and testing compounds that can activate or stabilize the channel.

Frequently Asked Questions

What is a potassium channel?

A potassium channel is a protein pore in the membrane of a cell that allows potassium ions to pass through. In nerve cells, these channels help control electrical signaling. They can make a nerve cell less likely to fire, acting like a brake on nerve activity. TWIK-1 is one specific type of potassium channel.

How is this different from other pain research?

Many pain studies focus on receptors that detect pain directly, such as those that respond to heat or pressure. This study is different because it identifies a mechanism in the spinal cord that regulates the balance between touch and pain. It shows that the same protein can control both sensations, which is a new way of thinking about how the nervous system processes sensory information.

When will a treatment based on this discovery be available?

It will likely take many years. The research is at a preclinical stage, meaning it has been tested only in mice. Scientists need to confirm that TWIK-1 works the same way in humans. Then they must develop drugs that can target this channel safely. Clinical trials would follow. Even if all goes well, a treatment would not be available for at least several years.

This is an original report by Vital Signs Today, informed by reporting from Medical Xpress. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.